Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Oct 18;17:346. doi: 10.1186/s12888-017-1507-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — Selection of the study population. Abbreviations: LAI, long-acting injectable; OAT, oral antipsychotic therapy; PP, paliperidone palmitate; REACH-OUT, Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes study. Notes: Reasons for REACH-OUT ineligibility (N = 99) included unknown or ineligible age (N = 34, 34%), most recent antipsychotic unknown or not study-eligible (N = 22, 22%), did not meet diagnostic criteria for schizophrenia or bipolar I disorder (N = 18, 18%), patient unwilling to complete scheduled study interviews (N = 17, 17%), patient participating in concurrent clinical study (N = 4, 4%), and patient did not consent (N = 4, 4%)